<code id='6B7F358627'></code><style id='6B7F358627'></style>
    • <acronym id='6B7F358627'></acronym>
      <center id='6B7F358627'><center id='6B7F358627'><tfoot id='6B7F358627'></tfoot></center><abbr id='6B7F358627'><dir id='6B7F358627'><tfoot id='6B7F358627'></tfoot><noframes id='6B7F358627'>

    • <optgroup id='6B7F358627'><strike id='6B7F358627'><sup id='6B7F358627'></sup></strike><code id='6B7F358627'></code></optgroup>
        1. <b id='6B7F358627'><label id='6B7F358627'><select id='6B7F358627'><dt id='6B7F358627'><span id='6B7F358627'></span></dt></select></label></b><u id='6B7F358627'></u>
          <i id='6B7F358627'><strike id='6B7F358627'><tt id='6B7F358627'><pre id='6B7F358627'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:9
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          FogPharma raises $145 million in rare Series E round
          FogPharma raises $145 million in rare Series E round

          FogPharmaCEOMathaiMammenBostonGlobePhotoImportOncologystartupFogPharmajustcloseda$145millionSeriesEr

          read more
          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more

          New chief aims to remake Sanofi Genzyme

          NewSanofiGenzymepresidentBillSiboldisthefirstpersonwithoutanytiestoHenriTermeer(inset)toleadthecompa